Amyloid-Beta-Exposed Neurons

Amyloid-Beta-Exposed Neurons

Overview

Amyloid-Beta-Exposed Neurons

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Amyloid-Beta-Exposed Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000169](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000169](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)</td>
</tr>
</table>

Amyloid Beta Exposed Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- taxonomy-enrichment --> [@masters2023]

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000169)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)
• [OBO Foundry (CL:0000169)](http://purl.obolibrary.org/obo/CL_0000169)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000169)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000169)
• [OBO Foundry (CL:0000169)](http://purl.obolibrary.org/obo/CL_0000169)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Introduction

Neurons exposed to amyloid-beta (Aβ) plaques and oligomers undergo synaptic dysfunction, cellular stress, and eventually death in Alzheimer's disease (AD). Aβ is considered the initiating factor in the amyloid cascade hypothesis.

Amyloid Precursor Protein (APP) Processing

Normal Processing (non-amyloidogenic)

• α-secretase cleavage: Produces sAPPα and CTFα
• Product: Soluble fragment, non-amyloidogenic pathway
• Physiological role: Synaptic plasticity, neuroprotection

Pathological Processing (amyloidogenic)

• β-secretase (BACE1): Produces sAPPβ and C99
• γ-secretase: Generates Aβ peptides (Aβ40, Aβ42)
• Aβ42: More aggregation-prone, primary pathogenic species

Aβ Toxicity Mechanisms

Synaptic Dysfunction

• Receptor interference: Aβ binds to numerous synaptic receptors
• LTPmechanisms/long-term-potentiation) impairment: Long-term potentiation blocked
• glutamate toxicity: Excitatory toxicity via NMDA receptors
• Synaptic loss: Early correlate of cognitive decline

Cellular Stress Pathways

• Oxidative stress: ROS production, lipid peroxidation
• ER stress: Unfolded protein response activation
• Mitochondrial dysfunction: Complex IV inhibition
• Calcium dysregulation: Homeostasis disruption

Neuroinflammation

• Microglial activation: Chronic neuroinflammation
• Cytokine release: IL-1β, TNF-α, IL-6
• Complement activation: Synaptic pruning enhancement

Neuronal Susceptibility

Intrinsic Factors

• High metabolic demand: Active neurons more vulnerable
• Mitochondrial burden: High ROS production
• Calcium handling: Dysregulation triggers apoptosis
• Aging: Reduced proteostasis capacity

Circuit-Specific Vulnerability

• Layer 2/3 cortical neurons: Early Aβ deposition
• CA1 pyramidal cells: Synaptic loss in stratum radiatum
• Parvalbumin interneurons: Network disruption

Therapeutic Implications

Aβ-Targeting Approaches

• Immunotherapies: Aduhelm, Lecanemab, Donanemab
• BACE inhibitors: Prevent Aβ production (challenging)
• Anti-aggregation agents: Prevent oligomer formation
• Passive immunization: Antibody delivery

Cross-Links

• [Amyloid Precursor Protein](/mechanisms/dopaminergic-neuron-vulnerability)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade-hypothesis)
• [BACE](/mechanisms/dopaminergic-neuron-vulnerability)
• [Amyloid](/mechanisms/amyloid-cascade-hypothesis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Plaques](/mechanisms/dopaminergic-neuron-vulnerability)
• [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade-hypothesis)
• [Synaptic Toxicity](/mechanisms/dopaminergic-neuron-vulnerability)
• [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)

External Links

• [PubMed: Amyloid Beta Exposed Neurons](https://pubmed.ncbi.nlm.nih.gov/?term=amyloid+beta+exposed+neurons) - Literature search
• [Alzheimer's Association](https://www.alz.org/) - AD research
• [Cure Alzheimer Fund](https://www.curealz.org/) - Research funding

Overview

Amyloid Beta Exposed Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Amyloid Beta Exposed Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Amyloid-Beta-Exposed Neurons discovered through SciDEX knowledge graph analysis: